title: Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance?
abstract: The goal of this commentary is to review the most relevant topics concerning the clinical utility of ambulatory blood pressure (BP) monitoring, such as the state of the art "reference BP values", the importance of the discrepant situations between office and ambulatory BP (white-coat and masked hypertension) and those of the recommended clinical indications to now. From a small number of studies, operational thresholds to define hypertension have been established. They are useful tools even though more studies are necessary to create strong reference values. Ambulatory BP measurement is increasingly recognized as being indispensable to the diagnosis and management of hypertension, and it has contributed significantly to our understanding of hypertension by revealing or "unmasking" BP phenomena that were not readily apparent using traditional techniques of measurement in clinical practice. Ambulatory BP monitoring should be performed in adolescents with either office mild essential hypertension before starting antihypertensive drug treatment or a strong family history of hypertension or an early cardiovascular event. Obese children with normal office BP values will also benefit from ambulatory BP monitoring. Other indications are the assessment of refractory hypertension or drug-induced hypotension. Finally, additional BP information in chronic renal failure, diabetes, and autonomic neuropathy can be obtained by using ambulatory BP monitoring.
authors: Empar
authors: E
authors: Lurbe
authors: Josep
authors: J
authors: Redon
mesh_terms: D000293:Adolescent; D018660:Blood Pressure Monitoring, Ambulatory; D003937:Diagnosis, Differential; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000523:psychology; D009819:Office Visits
references: Pediatrics. 1987 Jan;79(1):1-25
references: 3797155
references: J Pediatr. 2004 Jan;144(1):7-16
references: 14722512
references: JAMA. 1988 Jan 8;259(2):225-8
references: 3336140
references: Pediatrics. 1996 Oct;98(4 Pt 1):649-58
references: 8885941
references: Hypertension. 2005 Apr;45(4):481-2
references: 15790959
references: Am J Hypertens. 1998 Apr;11(4 Pt 1):410-7
references: 9607378
references: Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
references: 15286277
references: Hypertension. 2005 Apr;45(4):493-8
references: 15767467
references: Arch Intern Med. 1988 May;148(5):1023-38
references: 3365073
references: Hypertension. 2000 Mar;35(3):807-13
references: 10720599
references: J Hypertens. 2002 Oct;20(10):1995-2007
references: 12359978
references: JAMA. 2004 Mar 17;291(11):1342-9
references: 15026401
references: Lancet. 1990 Mar 31;335(8692):765-74
references: 1969518
references: J Hypertens. 2006 Aug;24(8):1557-64
references: 16877958
references: Hypertension. 2006 May;47(5):820-1
references: 16567587
references: Hypertension. 2002 Dec;40(6):795-6
references: 12468559
references: Circulation. 2003 Mar 11;107(9):1297-302
references: 12628951
references: J Hypertens. 2003 Nov;21(11):2001-3
references: 14597838
references: J Pediatr. 2000 May;136(5):578-86
references: 10802487
references: J Hypertens. 1994 Dec;12(12):1417-23
references: 7706703
references: Hypertension. 2006 May;47(5):846-53
references: 16567588
references: Am J Hypertens. 2001 Sep;14(9 Pt 1):855-60
references: 11587149
references: J Fam Pract. 1991 Dec;33(6):617-23
references: 1744607
references: J Hypertens Suppl. 1985 Nov;3(2):S5-11
references: 3866844
references: J Hypertens Suppl. 2003 May;21(2):S11-8
references: 12929902
references: Pediatr Nephrol. 2005 Aug;20(8):1151-5
references: 15947982
references: J Hypertens. 1997 Jan;15(1):3-17
references: 9050965
references: Circulation. 1975 Jun;51(6):1101-6
references: 1132100
references: Am J Hypertens. 1995 Jul;8(7):657-65
references: 7546488
references: Circulation. 2002 Jul 2;106(1):143-60
references: 12093785
references: Lancet. 1988 Aug 13;2(8607):397
references: 2899801